Peptide level immunoaffinity enrichment enhances ubiquitination site identification on individual proteins

Molecular and Cellular Proteomics

Volumn 13, Issue 1, 2014, Pages 145-156

  Anania, Veronica G ^a   Pham, Victoria C ^a   Huang, Xiaodong ^a   Masselot, Alexandre ^b   Lill, Jennie R ^a   Kirkpatrick, Donald S ^a,b  

^a Department of Protein Chemistry ^*  (United States)

^b GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISHEVELLED 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PEPTIDE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; TRIPEPTIDE;

ANTIBODY AFFINITY; ARTICLE; COMPLEX FORMATION; ENDOPLASMIC RETICULUM STRESS; INTERMETHOD COMPARISON; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; UBIQUITINATION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ENDOPLASMIC RETICULUM STRESS; HUMANS; PEPTIDES; PHOSPHOPROTEINS; PROTEIN INTERACTION MAPS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; PROTEOLYSIS; RECEPTOR, ERBB-2; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; UBIQUITINATION;

EID: 84891801891     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M113.031062     Document Type: Article

References (48)

1. Pickart, C. M. (2001) Mechanisms underlying ubiquitination. Ann. Rev. Biochem. 70, 503-533
2. Hoeller, D., and Dikic, I. (2009) Targeting the ubiquitin system in cancer therapy. Nature 458, 438-444
3. Kong, F., Zhang, J., Li, Y., Hao, X., Ren, X., Li, H., and Zhou, P. (2013) Engineering a single ubiquitin ligase for the selective degradation of all activated ErbB receptor tyrosine kinases. Oncogene
4. Sharma, V., Antonacopoulou, A. G., Tanaka, S., Panoutsopoulos, A. A., Bravou, V., Kalofonos, H. P., and Episkopou, V. (2011) Enhancement of TGF-beta signaling responses by the E3 ubiquitin ligase Arkadia provides tumor suppression in colorectal cancer. Cancer Res. 71, 6438-6449
5. Ueki, T., Park, J. H., Nishidate, T., Kijima, K., Hirata, K., Nakamura, Y., and Katagiri, T. (2009) Ubiquitination and downregulation of BRCA1 by ubiquitin- conjugating enzyme E2T overexpression in human breast cancer cells. Cancer Res. 69, 8752-8760
6. Yang, Y., Kitagaki, J., Dai, R. M., Tsai, Y. C., Lorick, K. L., Ludwig, R. L., Pierre, S. A., Jensen, J. P., Davydov, I. V., Oberoi, P., Li, C. C., Kenten, J. H., Beutler, J. A., Vousden, K. H., and Weissman, A. M. (2007) Inhibitors of ubiquitin-activating enzyme (E1), a new class of potential cancer therapeutics. Cancer Res. 67, 9472-9481
7. Zhi, X., Zhao, D., Wang, Z., Zhou, Z., Wang, C., Chen, W., Liu, R., and Chen, C. (2013) E3 ubiquitin ligase RNF126 promotes cancer cell proliferation by targeting the tumor suppressor p21 for ubiquitin-mediated degradation. Cancer Res. 73, 385-394
8. Balasubramanyam, M., Sampathkumar, R., and Mohan, V. (2005) Is insulin signaling molecules misguided in diabetes for ubiquitin-proteasome mediated degradation? Mol. Cell. Biochem. 275, 117-125
9. Cohen, P., and Tcherpakov, M. (2010) Will the ubiquitin system furnish as many drug targets as protein kinases? Cell 143, 686-693
10. Sheng, Z., Zhang, S., Bustos, D., Kleinheinz, T., Le Pichon, C. E., Dominguez, S. L., Solanoy, H. O., Drummond, J., Zhang, X., Ding, X., Cai, F., Song, Q., Li, X., Yue, Z., van der Brug, M. P., Burdick, D. J., Gunzner- Toste, J., Chen, H., Liu, X., Estrada, A. A., Sweeney, Z. K., Scearce- Levie, K., Moffat, J. G., Kirkpatrick, D. S., and Zhu, H. (2012) Ser1292 autophosphorylation is an indicator of LRRK2 kinase activity and contributes to the cellular effects of PD mutations. Science Translational Med. 4, 164ra161
11. Dueber, E. C., Schoeffler, A. J., Lingel, A., Elliott, J. M., Fedorova, A. V., Giannetti, A. M., Zobel, K., Maurer, B., Varfolomeev, E., Wu, P., Wallweber, H. J., Hymowitz, S. G., Deshayes, K., Vucic, D., and Fairbrother, W. J. (2011) Antagonists induce a conformational change in cIAP1 that promotes autoubiquitination. Science 334, 376-380
12. Ernst, A., Avvakumov, G., Tong, J., Fan, Y., Zhao, Y., Alberts, P., Persaud, A., Walker, J. R., Neculai, A. M., Neculai, D., Vorobyov, A., Garg, P., Beatty, L., Chan, P. K., Juang, Y. C., Landry, M. C., Yeh, C., Zeqiraj, E., Karamboulas, K., Allali-Hassani, A., Vedadi, M., Tyers, M., Moffat, J., Sicheri, F., Pelletier, L., Durocher, D., Raught, B., Rotin, D., Yang, J., Moran, M. F., Dhe-Paganon, S., and Sidhu, S. S. (2013) A strategy for modulation of enzymes in the ubiquitin system. Science 339, 590-595
13. Mollah, S., Wertz, I. E., Phung, Q., Arnott, D., Dixit, V. M., and Lill, J. R. (2007) Targeted mass spectrometric strategy for global mapping of ubiquitination on proteins. Rapid Commun. Mass Spectrom. RCM 21, 3357-3364
14. Kirkpatrick, D. S., Denison, C., and Gygi, S. P. (2005) Weighing in on ubiquitin: the expanding role of mass-spectrometry-based proteomics. Nat. Cell Biol. 7, 750-757
15. Peng, J., Schwartz, D., Elias, J. E., Thoreen, C. C., Cheng, D., Marsischky, G., Roelofs, J., Finley, D., and Gygi, S. P. (2003) A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 21, 921-926
16. Danielsen, J. M., Sylvestersen, K. B., Bekker-Jensen, S., Szklarczyk, D., Poulsen, J. W., Horn, H., Jensen, L. J., Mailand, N., and Nielsen, M. L. (2011) Mass spectrometric analysis of lysine ubiquitylation reveals promiscuity at site level. Mol. Cell. Proteomics 10, M110 003590
17. Bustos, D., Bakalarski, C. E., Yang, Y., Peng, J., and Kirkpatrick, D. S. (2012) Characterizing ubiquitination sites by peptide-based immunoaffinity enrichment. Mol. Cell. Proteomics 11, 1529-1540
18. Kim, W., Bennett, E. J., Huttlin, E. L., Guo, A., Li, J., Possemato, A., Sowa, M. E., Rad, R., Rush, J., Comb, M. J., Harper, J. W., and Gygi, S. P. (2011) Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol. Cell 44, 325-340
19. Udeshi, N. D., Svinkina, T., Mertins, P., Kuhn, E., Mani, D. R., Qiao, J. W., and Carr, S. A. (2013) Refined Preparation and Use of Anti-diglycine Remnant (K-{varepsilon}-GG) Antibody Enables Routine Quantification of 10,000s of Ubiquitination Sites in Single Proteomics Experiments. Mol. Cell. Proteomics 12, 825-831
20. Albin, J. S., Anderson, J. S., Johnson, J. R., Harjes, E., Matsuo, H., Krogan, N. J., and Harris, R. S. (2013) Dispersed Sites of HIV Vif-Dependent Polyubiquitination in the DNA Deaminase APOBEC3F. J. Mol. Biol.
21. Rappsilber, J., Mann, M., and Ishihama, Y. (2007) Protocol for micropurification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protocols 2, 1896-1906
22. Rush, J., Moritz, A., Lee, K. A., Guo, A., Goss, V. L., Spek, E. J., Zhang, H., Zha, X. M., Polakiewicz, R. D., and Comb, M. J. (2005) Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23, 94-101
23. Phu, L., Izrael-Tomasevic, A., Matsumoto, M. L., Bustos, D., Dynek, J. N., Fedorova, A. V., Bakalarski, C. E., Arnott, D., Deshayes, K., Dixit, V. M., Kelley, R. F., Vucic, D., and Kirkpatrick, D. S. (2011) Improved quantitative mass spectrometry methods for characterizing complex ubiquitin signals. Mol. Cell. Proteomics 10, M110 003756
24. Huttlin, E. L., Jedrychowski, M. P., Elias, J. E., Goswami, T., Rad, R., Beausoleil, S. A., Villen, J., Haas, W., Sowa, M. E., and Gygi, S. P. (2010) A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174-1189
25. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-3567
26. Bakalarski, C. E., Elias, J. E., Villen, J., Haas, W., Gerber, S. A., Everley, P. A., and Gygi, S. P. (2008) The impact of peptide abundance and dynamic range on stable-isotope-based quantitative proteomic analyses. J. Proteome Res. 7, 4756-4765
27. Elias, J. E., and Gygi, S. P. (2010) Target-decoy search strategy for mass spectrometry-based proteomics. Meth. Mol. Biol. 604, 55-71
28. Zhang, Y., Appleton, B. A., Wiesmann, C., Lau, T., Costa, M., Hannoush, R. N., and Sidhu, S. S. (2009) Inhibition of Wnt signaling by Dishevelled PDZ peptides. Nat. Chem. Biol. 5, 217-219
29. Angers, S., Thorpe, C. J., Biechele, T. L., Goldenberg, S. J., Zheng, N., MacCoss, M. J., and Moon, R. T. (2006) The KLHL12-Cullin-3 ubiquitin ligase negatively regulates the Wnt-beta-catenin pathway by targeting Dishevelled for degradation. Nat. Cell Biol. 8, 348-357
30. Peters, J. M., McKay, R. M., McKay, J. P., and Graff, J. M. (1999) Casein kinase I transduces Wnt signals. Nature 401, 345-350
31. Willert, K., Brink, M., Wodarz, A., Varmus, H., and Nusse, R. (1997) Casein kinase 2 associates with and phosphorylates dishevelled. EMBO J. 16, 3089-3096
32. Huang, X., McGann, J. C., Liu, B. Y., Hannoush, R. N., Lill, J. R., Pham, V., Newton, K., Kakunda, M., Liu, J., Yu, C., Hymowitz, S. G., Hongo, J. A., Wynshaw-Boris, A., Polakis, P., Harland, R. M., and Dixit, V. M. (2013) Phosphorylation of Dishevelled by Protein Kinase RIPK4 Regulates Wnt Signaling. Science 339, 1441-1445
33. Yu, H., Kaung, G., Kobayashi, S., and Kopito, R. R. (1997) Cytosolic degradation of T-cell receptor alpha chains by the proteasome. J. Biol. Chem. 272, 20800-20804
34. Yu, H., and Kopito, R. R. (1999) The role of multiubiquitination in dislocation and degradation of the alpha subunit of the T cell antigen receptor. J. Biol. Chem. 274, 36852-36858
35. Anania, V. G., Bustos, D. J., Lill, J. R., Kirkpatrick, D. S., and Coscoy, L. (2013) A Novel Peptide-Based SILAC Method to Identify the Posttranslational Modifications Provides Evidence for Unconventional Ubiquitination in the ER-Associated Degradation Pathway. Int. J. Proteomics 2013, 857918
36. Marx, C., Held, J. M., Gibson, B. W., and Benz, C. C. (2010) ErbB2 trafficking and degradation associated with K48 and K63 polyubiquitination. Cancer research 70, 3709-3717
37. Mimnaugh, E. G., Chavany, C., and Neckers, L. (1996) Polyubiquitination and proteasomal degradation of the p185c-erbB-2 receptor proteintyrosine kinase induced by geldanamycin. The Journal of biological chemistry 271, 22796-22801
38. Padron, D., Sato, M., Shay, J. W., Gazdar, A. F., Minna, J. D., and Roth, M. G. (2007) Epidermal growth factor receptors with tyrosine kinase domain mutations exhibit reduced Cbl association, poor ubiquitylation, and down-regulation but are efficiently internalized. Cancer research 67, 7695-7702
39. Frescas, D., and Pagano, M. (2008) Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nature reviews. Cancer 8, 438-449
40. Huang, F., Kirkpatrick, D., Jiang, X., Gygi, S., and Sorkin, A. (2006) Differential regulation of EGF receptor internalization and degradation by multiubiquitination within the kinase domain. Molecular cell 21, 737-748
41. Lopez-Otin, C., and Hunter, T. (2010) The regulatory crosstalk between kinases and proteases in cancer. Nat. Rev. Cancer 10, 278-292
42. Wagner, S. A., Beli, P., Weinert, B. T., Nielsen, M. L., Cox, J., Mann, M., and Choudhary, C. (2011) A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol. Cell. Proteomics : MCP 10, M111 013284
43. Huang, F., Zeng, X., Kim, W., Balasubramani, M., Fortian, A., Gygi, S. P., Yates, N. A., and Sorkin, A. (2013) Lysine 63-linked polyubiquitination is required for EGF receptor degradation. Proc. Natl. Acad. Sci. U. S. A. 110, 15722-15727
44. Aertgeerts, K., Skene, R., Yano, J., Sang, B. C., Zou, H., Snell, G., Jennings, A., Iwamoto, K., Habuka, N., Hirokawa, A., Ishikawa, T., Tanaka, T., Miki, H., Ohta, Y., and Sogabe, S. (2011) Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein. J. Biol. Chem. 286, 18756-18765
45. Nikolich-Zugich, J., Slifka, M. K., and Messaoudi, I. (2004) The many important facets of T-cell repertoire diversity. Nat. Rev. Immunology 4, 123-132
46. Shuford, C. M., Sederoff, R. R., Chiang, V. L., and Muddiman, D. C. (2012) Peptide production and decay rates affect the quantitative accuracy of protein cleavage isotope dilution mass spectrometry (PC-IDMS). Mol. Cell. Proteomics 11, 814-823
47. Havlis, J., and Shevchenko, A. (2004) Absolute quantification of proteins in solutions and in polyacrylamide gels by mass spectrometry. Anal. Chem. 76, 3029-3036
48. Kirkpatrick, D. S., Bustos, D. J., Dogan, T., Chan, J., Phu, L., Young, A., Friedman, L. S., Belvin, M., Song, Q., Bakalarski, C. E., and Hoeflich, K. P. (2013) Phosphoproteomic characterization of DNA damage response in melanoma cells following MEK/PI3K dual inhibition. Proceedings of the National Academy of Sciences of the United States of America 110, 19426-19431